fluticasone propionate 500 MCG / salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG) per ACTUAT Dry Powder Inhaler, 60 ACTUAT
- RxCUI
- 896228
- RxNorm name
- fluticasone propionate 500 MCG / salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG) per ACTUAT Dry Powder Inhaler, 60 ACTUAT
- Display name
- fluticasone propionate 500 MCG / salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG) per ACTUAT Dry Powder Inhaler, 60 ACTUAT
- Full name
- fluticasone propionate 500 MCG / salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG) per ACTUAT Dry Powder Inhaler, 60 ACTUAT
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:21
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ADVAIR DISKUS | FLUTICASONE PROPIONATE AND SALMETEROL | A-S Medication Solutions | cf306656-0d4c-4edd-9d6a-3471f99484e6 | 2026-04-26 | Warnings, Adverse reactions | 896228 |
| Fluticasone propionate and Salmeterol | FLUTICASONE PROPIONATE AND SALMETEROL | Cipla USA Inc. | 1349a04c-2024-42b9-b81d-a7d995716ade | 2026-04-01 | Warnings, Adverse reactions | 896228 |
| ADVAIR DISKUS | FLUTICASONE PROPIONATE AND SALMETEROL | GlaxoSmithKline LLC | 4eeb5f6a-593f-4a9e-9692-adefa2caf8fc | 2026-03-26 | Warnings, Adverse reactions | 896228 |
| ADVAIR DISKUS | FLUTICASONE PROPIONATE AND SALMETEROL | A-S Medication Solutions | 17dd0a86-8161-4aa9-9b90-a23d81b38164 | 2025-08-08 | Warnings, Adverse reactions | 896228 |
| fluticasone propionate and salmeterol | FLUTICASONE PROPIONATE AND SALMETEROL | Hikma Pharmaceuticals USA Inc. | f9fcfc90-3677-4a9b-900e-44417d50d507 | 2024-12-05 | Warnings, Adverse reactions | 896228 |
| Fluticasone Propionate and Salmeterol DISKUS | FLUTICASONE PROPIONATE AND SALMETEROL | Prasco Laboratories | 6eb6ddac-fa26-43b3-bf3e-5b7b58138fdc | 2023-07-19 | Warnings, Adverse reactions | 896228 |
| Fluticasone Propionate and Salmeterol DISKUS | FLUTICASONE PROPIONATE AND SALMETEROL | A-S Medication Solutions | ccf98c0a-fc40-4e08-bdf2-145fe4537db5 | 2023-02-06 | Warnings, Adverse reactions | 896228 |
| fluticasone propionate and salmeterol | FLUTICASONE PROPIONATE AND SALMETEROL | Teva Pharmaceuticals USA, Inc. | ce347bf4-4cc1-46dc-b5f1-6f8ff48da84b | 2022-09-28 | Warnings, Adverse reactions | 896228 |
| Wixela Inhub | FLUTICASONE PROPIONATE AND SALMETEROL | Mylan Pharmaceuticals Inc. | 3beef422-8a07-4a45-9ba6-414511e4b7e2 | 2022-08-29 | Warnings, Adverse reactions | 896228 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| cf306656-0d4c-4edd-9d6a-3471f99484e6 | fluticasone propionate/salmeterol 500/50 MCG/INHAL Dry Powder Inhaler, 60 Blisters [PSN] · 60 ACTUAT fluticasone propionate 0.5 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [SCD] · fluticasone propionate 0.5 MG / salmeterol 0.05 MG per ACTUAT Dry Powder Inhaler, 60 ACTUAT [SY] · fluticasone propionate 500 MCG / salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG) per ACTUAT Dry Powder Inhaler, 60 ACTUAT [SY] | 4 | 37 | These highlights do not include all the information needed to use ADVAIR DISKUS safely and effectively. See full prescribing information for ADVAIR DISKUS. ADVAIR DISKUS (fluticasone propionate and salmeterol inhalation powder), for oral inhalation use Initial U.S. Approval: 2000 | 20260426 |
| 4eeb5f6a-593f-4a9e-9692-adefa2caf8fc | fluticasone propionate/salmeterol 500/50 MCG/INHAL Dry Powder Inhaler, 60 Blisters [PSN] · 60 ACTUAT fluticasone propionate 0.5 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [SCD] · fluticasone propionate 0.5 MG / salmeterol 0.05 MG per ACTUAT Dry Powder Inhaler, 60 ACTUAT [SY] · fluticasone propionate 500 MCG / salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG) per ACTUAT Dry Powder Inhaler, 60 ACTUAT [SY] | 4 | 32 | These highlights do not include all the information needed to use ADVAIR DISKUS safely and effectively. See full prescribing information for ADVAIR DISKUS. ADVAIR DISKUS (fluticasone propionate and salmeterol inhalation powder), for oral inhalation use Initial U.S. Approval: 2000 | 20260326 |
| 6eb6ddac-fa26-43b3-bf3e-5b7b58138fdc | fluticasone propionate/salmeterol 500/50 MCG/INHAL Dry Powder Inhaler, 60 Blisters [PSN] · 60 ACTUAT fluticasone propionate 0.5 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [SCD] · fluticasone propionate 0.5 MG / salmeterol 0.05 MG per ACTUAT Dry Powder Inhaler, 60 ACTUAT [SY] · fluticasone propionate 500 MCG / salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG) per ACTUAT Dry Powder Inhaler, 60 ACTUAT [SY] | 4 | 14 | These highlights do not include all the information needed to use Fluticasone Propionate/Salmeterol DISKUS safely and effectively. See full prescribing information for Fluticasone Propionate/Salmeterol DISKUS. Fluticasone Propionate/Salmeterol DISKUS inhalation powder, for oral inhalation use Initial U.S. Approval: 2000 | 20230719 |
| 17dd0a86-8161-4aa9-9b90-a23d81b38164 | fluticasone propionate/salmeterol 500/50 MCG/INHAL Dry Powder Inhaler, 60 Blisters [PSN] · 60 ACTUAT fluticasone propionate 0.5 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [SCD] · fluticasone propionate 0.5 MG / salmeterol 0.05 MG per ACTUAT Dry Powder Inhaler, 60 ACTUAT [SY] · fluticasone propionate 500 MCG / salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG) per ACTUAT Dry Powder Inhaler, 60 ACTUAT [SY] | 4 | 10 | These highlights do not include all the information needed to use ADVAIR DISKUS safely and effectively. See full prescribing information for ADVAIR DISKUS. ADVAIR DISKUS (fluticasone propionate and salmeterol inhalation powder), for oral inhalation use Initial U.S. Approval: 2000 | 20250808 |
| ccf98c0a-fc40-4e08-bdf2-145fe4537db5 | fluticasone propionate/salmeterol 500/50 MCG/INHAL Dry Powder Inhaler, 60 Blisters [PSN] · 60 ACTUAT fluticasone propionate 0.5 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [SCD] · fluticasone propionate 0.5 MG / salmeterol 0.05 MG per ACTUAT Dry Powder Inhaler, 60 ACTUAT [SY] · fluticasone propionate 500 MCG / salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG) per ACTUAT Dry Powder Inhaler, 60 ACTUAT [SY] | 4 | 9 | These highlights do not include all the information needed to use Fluticasone Propionate/Salmeterol DISKUS safely and effectively. See full prescribing information for Fluticasone Propionate/Salmeterol DISKUS. Fluticasone Propionate/Salmeterol DISKUS inhalation powder, for oral inhalation use Initial U.S. Approval: 2000 | 20230206 |
| f9fcfc90-3677-4a9b-900e-44417d50d507 | fluticasone propionate/salmeterol 500/50 MCG/INHAL Dry Powder Inhaler, 60 Blisters [PSN] · 60 ACTUAT fluticasone propionate 0.5 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [SCD] · fluticasone propionate 0.5 MG / salmeterol 0.05 MG per ACTUAT Dry Powder Inhaler, 60 ACTUAT [SY] · fluticasone propionate 500 MCG / salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG) per ACTUAT Dry Powder Inhaler, 60 ACTUAT [SY] | 4 | 7 | These highlights do not include all the information needed to use FLUTICASONE PROPIONATE and SALMETEROL INHALATION POWDER safely and effectively. See full prescribing information for FLUTICASONE PROPIONATE and SALMETEROL INHALATION POWDER. FLUTICASONE PROPIONATE and SALMETEROL inhalation powder, for oral inhalation use Initial U.S. Approval: 2000 | 20241205 |
| ce347bf4-4cc1-46dc-b5f1-6f8ff48da84b | fluticasone propionate/salmeterol 500/50 MCG/INHAL Dry Powder Inhaler, 60 Blisters [PSN] · 60 ACTUAT fluticasone propionate 0.5 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [SCD] · fluticasone propionate 0.5 MG / salmeterol 0.05 MG per ACTUAT Dry Powder Inhaler, 60 ACTUAT [SY] · fluticasone propionate 500 MCG / salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG) per ACTUAT Dry Powder Inhaler, 60 ACTUAT [SY] | 4 | 6 | These highlights do not include all the information needed to use FLUTICASONE PROPIONATE AND SALMETEROL INHALATION POWDER safely and effectively. See full prescribing information for FLUTICASONE PROPIONATE AND SALMETEROL INHALATION POWDER. FLUTICASONE PROPIONATE and SALMETEROL inhalation powder, for oral inhalation use Initial U.S. Approval: 2000 | 20220928 |
| 3beef422-8a07-4a45-9ba6-414511e4b7e2 | fluticasone propionate/salmeterol 500/50 MCG/INHAL Dry Powder Inhaler, 60 Blisters [PSN] · 60 ACTUAT fluticasone propionate 0.5 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [SCD] · fluticasone propionate 0.5 MG / salmeterol 0.05 MG per ACTUAT Dry Powder Inhaler, 60 ACTUAT [SY] · fluticasone propionate 500 MCG / salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG) per ACTUAT Dry Powder Inhaler, 60 ACTUAT [SY] | 4 | 6 | These highlights do not include all the information needed to use WIXELA INHUB ® safely and effectively. See full prescribing information for WIXELA INHUB ® . WIXELA INHUB ® (fluticasone propionate and salmeterol inhalation powder), for oral inhalation use Initial U.S. Approval: 2000 | 20220829 |
| 197b7628-71aa-4fa2-94df-d617c0f2c986 | fluticasone propionate/salmeterol 500/50 MCG/INHAL Dry Powder Inhaler, 60 Blisters [PSN] · 60 ACTUAT fluticasone propionate 0.5 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [SCD] · fluticasone propionate 0.5 MG / salmeterol 0.05 MG per ACTUAT Dry Powder Inhaler, 60 ACTUAT [SY] · fluticasone propionate 500 MCG / salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG) per ACTUAT Dry Powder Inhaler, 60 ACTUAT [SY] | 4 | 1 | These highlights do not include all the information needed to use Fluticasone Propionate/Salmeterol DISKUS safely and effectively. See full prescribing information for Fluticasone Propionate/Salmeterol DISKUS. Fluticasone Propionate/Salmeterol DISKUS inhalation powder, for oral inhalation use Initial U.S. Approval: 2000 | 20250805 |
| 9e0bdea8-df9b-4873-b24b-919cebff5edd | fluticasone propionate/salmeterol 500/50 MCG/INHAL Dry Powder Inhaler, 60 Blisters [PSN] · 60 ACTUAT fluticasone propionate 0.5 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [SCD] · fluticasone propionate 0.5 MG / salmeterol 0.05 MG per ACTUAT Dry Powder Inhaler, 60 ACTUAT [SY] · fluticasone propionate 500 MCG / salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG) per ACTUAT Dry Powder Inhaler, 60 ACTUAT [SY] | 4 | 1 | These highlights do not include all the information needed to use ADVAIR DISKUS safely and effectively. See full prescribing information for ADVAIR DISKUS. ADVAIR DISKUS 100/50 (fluticasone propionate 100 mcg and salmeterol 50 mcg inhalation powder) ADVAIR DISKUS 250/50 (fluticasone propionate 250 mcg and salmeterol 50 mcg inhalation powder) ADVAIR DISKUS 500/50 (fluticasone propionate 500 mcg and salmeterol 50 mcg inhalation powder) FOR ORAL INHALATION Initial U.S. Approval: 2000 | 20100901 |
| b20c1d84-5c49-47de-bd2e-f987ff67faef | fluticasone propionate/salmeterol 500/50 MCG/INHAL Dry Powder Inhaler, 60 Blisters [PSN] · 60 ACTUAT fluticasone propionate 0.5 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [SCD] · fluticasone propionate 0.5 MG / salmeterol 0.05 MG per ACTUAT Dry Powder Inhaler, 60 ACTUAT [SY] · fluticasone propionate 500 MCG / salmeterol 50 MCG (salmeterol xinafoate 72.5 MCG) per ACTUAT Dry Powder Inhaler, 60 ACTUAT [SY] | 4 | 1 | These highlights do not include all the information needed to use ADVAIR DISKUS safely and effectively. See full prescribing information for ADVAIR DISKUS. ADVAIR DISKUS 100/50 (fluticasone propionate 100 mcg and salmeterol 50 mcg inhalation powder) ADVAIR DISKUS 250/50 (fluticasone propionate 250 mcg and salmeterol 50 mcg inhalation powder) ADVAIR DISKUS 500/50 (fluticasone propionate 500 mcg and salmeterol 50 mcg inhalation powder) FOR ORAL INHALATION Initial U.S. Approval: 2000 | 20100621 |